Clinical Proteomics:Article Title: Proteomic analysis of the developing mammalian brain links PCDH19 to the Wnt/β-catenin signalling pathway.
Article Snippet: 15 18 Embryonic Postnatal 13 PPM1B MAP1B RPL8 MAP2 KCTD5 GAPDH CAPZA2 MYO18A SOGA3 EIF4B CLASP2 PRMT5 SPTAN1 A Molecular Function GOB C Cellular Component GO F-actin capping protein complex: n=3, FE=178.4 Cortical cytoskeleton: n=10, FE=38.1 Cortical actin cytoskeleton: n=8, FE=40.1 Dendritic filopodium: n=2, FE=317.2 Cuticular plate: n=3, FE=109.8 Actin cytoskeleton: n=19, FE=18.3 Dendritic spine neck: n=2, FE=135.9 Brush border: n=7, FE=24.9 Growth cone: n=9, FE=19.6 Site of polarized growth: n=9, FE=19 D Biological Process GO Neg. reg. of protein depolymerization: n=9, FE=54.2 Neg. reg. of protein-containing complex disassembly: n=9, FE=48.7 Reg. of protein depolymerization: n=9, FE=46 Protein depolymerization: n=10, FE=39.3 Actin filament depolymerization: n=7, FE=53.7 Neg. reg. of supramolecular fiber organization: n=12, FE=33.8 Neg. reg. of actin filament depolymerization: n=6, FE=58.3 Cellular protein complex disassembly: n=10, FE=33.3 Actin filament capping: n=5, FE=55.3 Protein-containing complex disassembly: n=10, FE=22.1 Subcellular ComponentE Cytosol: n=12 Cytoskeleton: n=8 Peroxisome: n=1 Mitochondrion: n=1 Golgi apparatus: n=3 Plasma Membrane: n=5 Nucleus: n=8 Extracellular: n=4 Cytoskeletal regulatory protein binding: n=3, FE=475.8 Glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity: n=2, FE=237.9 Actin filament binding: n=13, FE=30 Actin binding: n=19, FE=20.4 Filamin binding: n=2, FE=59.5 Cytoskeletal protein binding: n=24, FE=11.6 Transmembrane transporter binding: n=5, FE=16.5 Structural constituent of cytoskeleton: n=3, FE=20.1 Thyroid hormone receptor binding: n=2, FE=35.2 Protein phosphatase 1 binding: n=2, FE=31.7 Fig. 2 The PCDH19 interactome in the developing mouse brain.
Membrane:Article Title: Proteomic analysis of the developing mammalian brain links PCDH19 to the Wnt/β-catenin signalling pathway.
Article Snippet: 15 18 Embryonic Postnatal 13 PPM1B MAP1B RPL8 MAP2 KCTD5 GAPDH CAPZA2 MYO18A SOGA3 EIF4B CLASP2 PRMT5 SPTAN1 A Molecular Function GOB C Cellular Component GO F-actin capping protein complex: n=3, FE=178.4 Cortical cytoskeleton: n=10, FE=38.1 Cortical actin cytoskeleton: n=8, FE=40.1 Dendritic filopodium: n=2, FE=317.2 Cuticular plate: n=3, FE=109.8 Actin cytoskeleton: n=19, FE=18.3 Dendritic spine neck: n=2, FE=135.9 Brush border: n=7, FE=24.9 Growth cone: n=9, FE=19.6 Site of polarized growth: n=9, FE=19 D Biological Process GO Neg. reg. of protein depolymerization: n=9, FE=54.2 Neg. reg. of protein-containing complex disassembly: n=9, FE=48.7 Reg. of protein depolymerization: n=9, FE=46 Protein depolymerization: n=10, FE=39.3 Actin filament depolymerization: n=7, FE=53.7 Neg. reg. of supramolecular fiber organization: n=12, FE=33.8 Neg. reg. of actin filament depolymerization: n=6, FE=58.3 Cellular protein complex disassembly: n=10, FE=33.3 Actin filament capping: n=5, FE=55.3 Protein-containing complex disassembly: n=10, FE=22.1 Subcellular ComponentE Cytosol: n=12 Cytoskeleton: n=8 Peroxisome: n=1 Mitochondrion: n=1 Golgi apparatus: n=3 Plasma Membrane: n=5 Nucleus: n=8 Extracellular: n=4 Cytoskeletal regulatory protein binding: n=3, FE=475.8 Glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity: n=2, FE=237.9 Actin filament binding: n=13, FE=30 Actin binding: n=19, FE=20.4 Filamin binding: n=2, FE=59.5 Cytoskeletal protein binding: n=24, FE=11.6 Transmembrane transporter binding: n=5, FE=16.5 Structural constituent of cytoskeleton: n=3, FE=20.1 Thyroid hormone receptor binding: n=2, FE=35.2 Protein phosphatase 1 binding: n=2, FE=31.7 Fig. 2 The PCDH19 interactome in the developing mouse brain.
Protein Binding:Article Title: Proteomic analysis of the developing mammalian brain links PCDH19 to the Wnt/β-catenin signalling pathway.
Article Snippet: 15 18 Embryonic Postnatal 13 PPM1B MAP1B RPL8 MAP2 KCTD5 GAPDH CAPZA2 MYO18A SOGA3 EIF4B CLASP2 PRMT5 SPTAN1 A Molecular Function GOB C Cellular Component GO F-actin capping protein complex: n=3, FE=178.4 Cortical cytoskeleton: n=10, FE=38.1 Cortical actin cytoskeleton: n=8, FE=40.1 Dendritic filopodium: n=2, FE=317.2 Cuticular plate: n=3, FE=109.8 Actin cytoskeleton: n=19, FE=18.3 Dendritic spine neck: n=2, FE=135.9 Brush border: n=7, FE=24.9 Growth cone: n=9, FE=19.6 Site of polarized growth: n=9, FE=19 D Biological Process GO Neg. reg. of protein depolymerization: n=9, FE=54.2 Neg. reg. of protein-containing complex disassembly: n=9, FE=48.7 Reg. of protein depolymerization: n=9, FE=46 Protein depolymerization: n=10, FE=39.3 Actin filament depolymerization: n=7, FE=53.7 Neg. reg. of supramolecular fiber organization: n=12, FE=33.8 Neg. reg. of actin filament depolymerization: n=6, FE=58.3 Cellular protein complex disassembly: n=10, FE=33.3 Actin filament capping: n=5, FE=55.3 Protein-containing complex disassembly: n=10, FE=22.1 Subcellular ComponentE Cytosol: n=12 Cytoskeleton: n=8 Peroxisome: n=1 Mitochondrion: n=1 Golgi apparatus: n=3 Plasma Membrane: n=5 Nucleus: n=8 Extracellular: n=4 Cytoskeletal regulatory protein binding: n=3, FE=475.8 Glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity: n=2, FE=237.9 Actin filament binding: n=13, FE=30 Actin binding: n=19, FE=20.4 Filamin binding: n=2, FE=59.5 Cytoskeletal protein binding: n=24, FE=11.6 Transmembrane transporter binding: n=5, FE=16.5 Structural constituent of cytoskeleton: n=3, FE=20.1 Thyroid hormone receptor binding: n=2, FE=35.2 Protein phosphatase 1 binding: n=2, FE=31.7 Fig. 2 The PCDH19 interactome in the developing mouse brain.
Activity Assay:Article Title: Proteomic analysis of the developing mammalian brain links PCDH19 to the Wnt/β-catenin signalling pathway.
Article Snippet: 15 18 Embryonic Postnatal 13 PPM1B MAP1B RPL8 MAP2 KCTD5 GAPDH CAPZA2 MYO18A SOGA3 EIF4B CLASP2 PRMT5 SPTAN1 A Molecular Function GOB C Cellular Component GO F-actin capping protein complex: n=3, FE=178.4 Cortical cytoskeleton: n=10, FE=38.1 Cortical actin cytoskeleton: n=8, FE=40.1 Dendritic filopodium: n=2, FE=317.2 Cuticular plate: n=3, FE=109.8 Actin cytoskeleton: n=19, FE=18.3 Dendritic spine neck: n=2, FE=135.9 Brush border: n=7, FE=24.9 Growth cone: n=9, FE=19.6 Site of polarized growth: n=9, FE=19 D Biological Process GO Neg. reg. of protein depolymerization: n=9, FE=54.2 Neg. reg. of protein-containing complex disassembly: n=9, FE=48.7 Reg. of protein depolymerization: n=9, FE=46 Protein depolymerization: n=10, FE=39.3 Actin filament depolymerization: n=7, FE=53.7 Neg. reg. of supramolecular fiber organization: n=12, FE=33.8 Neg. reg. of actin filament depolymerization: n=6, FE=58.3 Cellular protein complex disassembly: n=10, FE=33.3 Actin filament capping: n=5, FE=55.3 Protein-containing complex disassembly: n=10, FE=22.1 Subcellular ComponentE Cytosol: n=12 Cytoskeleton: n=8 Peroxisome: n=1 Mitochondrion: n=1 Golgi apparatus: n=3 Plasma Membrane: n=5 Nucleus: n=8 Extracellular: n=4 Cytoskeletal regulatory protein binding: n=3, FE=475.8 Glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity: n=2, FE=237.9 Actin filament binding: n=13, FE=30 Actin binding: n=19, FE=20.4 Filamin binding: n=2, FE=59.5 Cytoskeletal protein binding: n=24, FE=11.6 Transmembrane transporter binding: n=5, FE=16.5 Structural constituent of cytoskeleton: n=3, FE=20.1 Thyroid hormone receptor binding: n=2, FE=35.2 Protein phosphatase 1 binding: n=2, FE=31.7 Fig. 2 The PCDH19 interactome in the developing mouse brain.
Binding Assay:Article Title: Proteomic analysis of the developing mammalian brain links PCDH19 to the Wnt/β-catenin signalling pathway.
Article Snippet: 15 18 Embryonic Postnatal 13 PPM1B MAP1B RPL8 MAP2 KCTD5 GAPDH CAPZA2 MYO18A SOGA3 EIF4B CLASP2 PRMT5 SPTAN1 A Molecular Function GOB C Cellular Component GO F-actin capping protein complex: n=3, FE=178.4 Cortical cytoskeleton: n=10, FE=38.1 Cortical actin cytoskeleton: n=8, FE=40.1 Dendritic filopodium: n=2, FE=317.2 Cuticular plate: n=3, FE=109.8 Actin cytoskeleton: n=19, FE=18.3 Dendritic spine neck: n=2, FE=135.9 Brush border: n=7, FE=24.9 Growth cone: n=9, FE=19.6 Site of polarized growth: n=9, FE=19 D Biological Process GO Neg. reg. of protein depolymerization: n=9, FE=54.2 Neg. reg. of protein-containing complex disassembly: n=9, FE=48.7 Reg. of protein depolymerization: n=9, FE=46 Protein depolymerization: n=10, FE=39.3 Actin filament depolymerization: n=7, FE=53.7 Neg. reg. of supramolecular fiber organization: n=12, FE=33.8 Neg. reg. of actin filament depolymerization: n=6, FE=58.3 Cellular protein complex disassembly: n=10, FE=33.3 Actin filament capping: n=5, FE=55.3 Protein-containing complex disassembly: n=10, FE=22.1 Subcellular ComponentE Cytosol: n=12 Cytoskeleton: n=8 Peroxisome: n=1 Mitochondrion: n=1 Golgi apparatus: n=3 Plasma Membrane: n=5 Nucleus: n=8 Extracellular: n=4 Cytoskeletal regulatory protein binding: n=3, FE=475.8 Glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity: n=2, FE=237.9 Actin filament binding: n=13, FE=30 Actin binding: n=19, FE=20.4 Filamin binding: n=2, FE=59.5 Cytoskeletal protein binding: n=24, FE=11.6 Transmembrane transporter binding: n=5, FE=16.5 Structural constituent of cytoskeleton: n=3, FE=20.1 Thyroid hormone receptor binding: n=2, FE=35.2 Protein phosphatase 1 binding: n=2, FE=31.7 Fig. 2 The PCDH19 interactome in the developing mouse brain.
|
Cytoskeleton Inc is a verified supplier 
Cytoskeleton Inc manufactures this product 